Ian D Davis

37PUBLICATIONS
249CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsPharmacogenomicsPacific Peoples community governance and decision making
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Oct 24, 2026
ENZARAD (ANZUP 1303): Phase 3 Trial of Enzalutamide With Androgen Deprivation Therapy and Radiation Therapy in High-Risk Localized or Locally Advanced Prostate Cancer.

|Oct 10, 2026
Australian Practical Guide on the Management of Muscle-Invasive Bladder Cancer.

|Sep 27, 2026
Insulin-Like Growth Factor Axis and Survival in Metastatic Hormone-Sensitive Prostate Cancer: Post-Hoc Analysis From the ENZAMET Phase 3 Trial.

|Jul 08, 2026
Development and Validation of a Computational Histology Artificial Intelligence-Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials.

|Jul 02, 2026
Germline CDK12 variants in aggressive prostate cancer.

|Jun 26, 2026
AI-Based Pathology Classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET Trial.

Pageof 7

Frequent Collaborators

13 joint publications

Martin Stockler

7 joint publications

Christopher J Sweeney

7 joint publications

Anthony M Joshua

5 joint publications

Louise Emmett